Decision to list medical devices supplied by Cardinal Health Australia 503 Pty Ltd

Source: Pharmac

What we’re doing

In summary this will result in:

• Urology products, continence products, surgical suction chest and wound drainage and non-dedicated and consumable infusion devices from Cardinal Health being listed in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020 under a national agreement that all DHBs may purchase under (“Agreement”); and
• DHBs being able to continue to purchase other suppliers’ brands of urology products, continence products, surgical suction, chest and wound drainage and non-dedicated and consumable infusion devices, as the Agreement is not for sole supply.

Any changes to the original proposal?

This decision was subject to a consultation letter dated 6 July 2020.

No changes were made to the original proposal as a result of consultation feedback.

Who we think will be most interested

• DHB clinical staff in a range of clinical settings including:
  • Ambulatory care
  • Intensive care
  • Infection control
  • Occupational health and safety
  • Perioperative care
  • Surgical and General Medical care
  • Surgeons – general and specialties
  • Anaesthetists
  • Nurses
  • Gastroenterologists
  • Urologists
  • Community-level care providers
• Suppliers and wholesalers 

Details about this decision

In 2018 PHARMAC issued Request for Proposals (“RFPs”) for:

These RFPs were for non-exclusive national agreements for listing in the Pharmaceutical Schedule.

After completing the evaluation processes, and consulting on the provisional Agreement reached with Cardinal Health, PHARMAC has decided to list Cardinal Health’s urology products, continence products, surgical suction chest and wound drainage and non-dedicated and consumable infusion devices in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020.

The list of products will be available on PHARMAC’s website from 1 September 2020, in both a PDF document and an Excel spreadsheet.

DHBs can continue to choose which urology products, continence products, surgical suction chest and wound drainage and non-dedicated and consumable infusion devices they purchase, including those from other suppliers.

DHBs that purchase urology products, continence products, surgical suction chest and wound drainage and non-dedicated and consumable infusion devices from Cardinal Health must do so under the terms and conditions, including pricing, in the Agreement from 1 September 2020.

The Agreement includes terms and conditions for training and education to be provided by the suppliers on the appropriate use of its urology products, continence products, surgical suction chest and wound drainage and non-dedicated and consumable infusion devices, which is to be provided at times and in formats as agreed with individual DHBs.

Our response to what you told us

We’re really grateful for the time people took to respond to this consultation. 

All consultation responses received by 30 July 2020 were considered in their entirety in making the decision to list medical devices from Cardinal Health.

A summary of the main themes raised in feedback and our responses to the feedback are set out below:

Theme	Comment
No technical or resource impacts anticipated as a result of the proposal.	Noted.
Support of the proposal.	Noted.

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.

MIL OSI